Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;2(1):69-88.
doi: 10.1038/kisup.2011.34.

Section 4: Contrast-induced AKI

No authors listed

Section 4: Contrast-induced AKI

No authors listed. Kidney Int Suppl (2011). 2012 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 13
Figure 13
Sample questionnaire. Asterisks denote questions with the highest association with abnormal renal function. Adapted from Choyke PL, Cady J, DePollar SL et al. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 1998; 4: 65–69 with permission.
Figure 14
Figure 14
Risk for contrast-induced nephropathy. (a) Iodixanol vs. iohexol and risk for contrast-induced nephropathy; (b) iodixanol vs. nonionic low-osmolar contrast media other than iohexol and risk for contrast-induced nephropathy. Reprinted from Heinrich MC, Haberle L, Muller V et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009; 250: 68–86 with permission, copyright 2009, from Radiological Society of North America; accessed http://radiology.rsna.org/content/250/1/68.long
Figure 15
Figure 15
Bicarbonate vs. saline and risk of CI-AKI. Reprinted from Zoungas S, Ninomiya T, Huxley R et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151: 631–638 with permission from American College of Physicians; accessed http://www.annals.org/content/151/9/631.full
Figure 16
Figure 16
NAC and bicarbonate vs. NAC for risk of CI-AKI. Reprinted from Brown, JR, Block CA, Malenka DJ et al. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Interv 2009; 2: 1116–1124, copyright 2009, with permission from American College of Cardiology Foundation; accessed http://interventions.onlinejacc.org/cgi/content/full/2/11/1116
See this image and copyright information in PMC

References

    1. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416 –1420. - PubMed
    1. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropat hy: a randomized controlled trial. JAMA. 2003;290:2284 –2291. - PubMed
    1. Beauchamp D, Labrecque G. Aminoglycoside nephrotoxicity: do time and frequency of administration matter. Curr Opin Crit Care. 2001;7:401 –408. - PubMed
    1. Kim MJ, Bertino JS, Jr, Erb TA, et al. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing. J Clin Pharmacol. 2004;44:696 –707. - PubMed
    1. Murry KR, McKinnon PS, Mitrzyk B, et al. Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside. Pharmacotherapy. 1999;19:1252 –1260. - PubMed